Andrea Da Silva

Andrea Da Silva

Auto-generated profile, based on publicly available information

Andrea Da Silva

Department of Urology The Royal Free London NHS Foundation Trust London UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
SCSelina Chiu
Selina Chiu
YTYvonne Tsitsiou
Yvonne Tsitsiou
ASAndrea Da Silva
Andrea Da Silva
CQCathy Qin
Cathy Qin
CFChristina Fotopoulou
Christina Fotopoulou
ARAnd Andrea G. Rockall
And Andrea G. Rockall
Chiu S, et al. Korean J Radiol. 2025 Jul;26:e64. https://doi.org/10.3348/kjr.2025.0357

1 October 2026 in BJU International
Verified
Journal Article
Open access
PDF file
BGBhargab Ghoshal
Bhargab Ghoshal
SNSarika Nalagatla
Sarika Nalagatla
MRMax Roberts
Max Roberts
AMAdam Mann
Adam Mann
DCDavid Cullen
David Cullen
ABAxel Bex
Axel Bex
Objectives: To develop and evaluate a complexity‐stratified referral pathway aimed at improving the sustainability, efficiency and resource utilisation of specialist multidisciplinary team (SMDT) meetings within a high‐volume tertiary renal cancer service. Patients and Methods: We performed a retrospective cohort study of benign and malignant renal cancer cases discussed at SMDT meetings between January and December 2023 at the Royal Free Specialist Centre for Kidney Cancer. Patient demographics, tumour characteristics, SMDT discussions and management outcomes of patients were analysed to identify protocolised lower complexity cases suitable for alternative MDT pathways. Based on these findings, dedicated Standard of Care (SoC) and Benign MDTs were developed and implemented to manage lower complexity renal cases outside the main SMDT. The impact of the revised referral structure on SMDT workload, discussion efficiency and specialist resource utilisation was subsequently evaluated. Results: In 2023, 2228 patients with benign and malignant renal pathology underwent 4154 SMDT discussions. Most patients (96.3%) required under seven discussions. Patients aged >70 years with renal masses <2 cm frequently underwent repeated SMDT review, despite surveillance or conservative management representing the most common management recommendation. Bosniak I–II cysts were predominantly discharged, whilst Bosniak IIF cysts were mainly managed with surveillance. Following implementation of the revised referral structure incorporating SoC and Benign MDTs, cases discussed at the main SMDT decreased from a mean of 83 to 63 patients with cancer per week, whilst discussion time per patient increased by 30.8%. The revised pathway also reduced the requirement for full SMDT attendance for protocolised cases. Conclusion: Complexity‐stratified MDT referral structure improved efficiency and sustainability by diverting lower complexity protocolised cases to dedicated Benign and SoC MDTs. This enabled the main SMDT to prioritise clinically complex decision making and optimise utilisation of specialist multidisciplinary expertise.